Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Altretamine.
Amineptin
Altretamine may increase the orthostatic hypotensive activities of Amineptine.
Amitriptyline
Altretamine may increase the orthostatic hypotensive activities of Amitriptyline.
Advertisement
Amoxapine
Altretamine may increase the orthostatic hypotensive activities of Amoxapine.
Amphetamine
Altretamine may increase the orthostatic hypotensive activities of Amphetamine.
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Altretamine.
Advertisement
Anhydrous Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Altretamine.
Anthrax immune globulin, human
The risk or severity of adverse effects can be increased when Altretamine is combined with Anthrax immune globulin human.
BCG Vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Altretamine.
Advertisement
BCG, Live, Connaught Strain
The risk or severity of adverse effects can be increased when Altretamine is combined with Bacillus calmette-guerin substrain connaught live antigen.
BCG, Live, Tice Strain
The risk or severity of adverse effects can be increased when Altretamine is combined with Bacillus calmette-guerin substrain tice live antigen.
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Altretamine.
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Altretamine.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Altretamine.
Clomipramine
Altretamine may increase the orthostatic hypotensive activities of Clomipramine.
Clozapine
The risk or severity of adverse effects can be increased when Altretamine is combined with Clozapine.
Cyclobenzaprine
Altretamine may increase the orthostatic hypotensive activities of Cyclobenzaprine.
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Altretamine.
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Altretamine.
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Altretamine.
Desipramine
Altretamine may increase the orthostatic hypotensive activities of Desipramine.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Altretamine.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Altretamine.
Digoxin
Digoxin may decrease the cardiotoxic activities of Altretamine.
Dipyrone
The risk or severity of myelosuppression can be increased when Metamizole is combined with Altretamine.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Altretamine.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Altretamine.
Dothiepin
Altretamine may increase the orthostatic hypotensive activities of Dosulepin.
Doxepin
Altretamine may increase the orthostatic hypotensive activities of Doxepin.
Fingolimod
Altretamine may increase the immunosuppressive activities of Fingolimod.
Furazolidone
Altretamine may increase the orthostatic hypotensive activities of Furazolidone.
Hepatitis A Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Altretamine is combined with Hepatitis A Vaccine.
Hepatitis B Surface Antigen Vaccine
The risk or severity of adverse effects can be increased when Altretamine is combined with Hepatitis B Vaccine (Recombinant).
Imipramine
Altretamine may increase the orthostatic hypotensive activities of Imipramine.
Iproniazid
Altretamine may increase the orthostatic hypotensive activities of Iproniazid.
Isocarboxazid
Altretamine may increase the orthostatic hypotensive activities of Isocarboxazid.
Leflunomide
The risk or severity of adverse effects can be increased when Altretamine is combined with Leflunomide.
Methylene blue
Altretamine may increase the orthostatic hypotensive activities of Methylene blue.
Minaprine
Altretamine may increase the orthostatic hypotensive activities of Minaprine.
Mirtazapine
Altretamine may increase the orthostatic hypotensive activities of Mirtazapine.
Moclobemide
Altretamine may increase the orthostatic hypotensive activities of Moclobemide.
Natalizumab
The risk or severity of adverse effects can be increased when Altretamine is combined with Natalizumab.
Nialamide
Altretamine may increase the orthostatic hypotensive activities of Nialamide.
Nortriptyline
Altretamine may increase the orthostatic hypotensive activities of Nortriptyline.
Ocrelizumab
Ocrelizumab may increase the immunosuppressive activities of Altretamine.
Opipramol
Altretamine may increase the orthostatic hypotensive activities of Opipramol.
Ouabain
Ouabain may decrease the cardiotoxic activities of Altretamine.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Altretamine.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Altretamine.
Pargyline
Altretamine may increase the orthostatic hypotensive activities of Pargyline.
Phenelzine
Altretamine may increase the orthostatic hypotensive activities of Phenelzine.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Altretamine.
Procarbazine
Altretamine may increase the orthostatic hypotensive activities of Procarbazine.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Altretamine.
Protriptyline
Altretamine may increase the orthostatic hypotensive activities of Protriptyline.
Pyridoxine
The therapeutic efficacy of Altretamine can be decreased when used in combination with Pyridoxine.
Rabies Immune Globulin, Human
The risk or severity of adverse effects can be increased when Altretamine is combined with Human rabies virus immune globulin.
Rabies Virus Vaccine Flury-Lep Strain
The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Altretamine.
Rasagiline
Altretamine may increase the orthostatic hypotensive activities of Rasagiline.
Roflumilast
Roflumilast may increase the immunosuppressive activities of Altretamine.
ROTAVIRUS VACCINE, LIVE
The risk or severity of adverse effects can be increased when Altretamine is combined with Rotavirus Vaccine.
Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)
The risk or severity of adverse effects can be increased when Altretamine is combined with Rubella virus vaccine.
Salmonella enterica subsp. enterica serovar typhi
The risk or severity of adverse effects can be increased when Altretamine is combined with Salmonella typhi ty21a live antigen.
Selegiline
Altretamine may increase the orthostatic hypotensive activities of Selegiline.
sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Altretamine.
Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Altretamine.
Tetanus Toxoid Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Altretamine is combined with Clostridium tetani toxoid antigen (formaldehyde inactivated).
Tianeptine
Altretamine may increase the orthostatic hypotensive activities of Tianeptine.
Tofacitinib
Altretamine may increase the immunosuppressive activities of Tofacitinib.
Toloxatone
Altretamine may increase the orthostatic hypotensive activities of Toloxatone.
Tranylcypromine
Altretamine may increase the orthostatic hypotensive activities of Tranylcypromine.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Altretamine.
Trimipramine
Altretamine may increase the orthostatic hypotensive activities of Trimipramine.
Typhoid Vaccine Live Ty21a
The risk or severity of adverse effects can be increased when Altretamine is combined with Salmonella typhi ty21a live antigen.
Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
The risk or severity of adverse effects can be increased when Altretamine is combined with Salmonella typhi ty2 vi polysaccharide antigen.
Varicella Virus Vaccine Live (Oka-Merck) strain
The risk or severity of adverse effects can be increased when Altretamine is combined with Varicella Zoster Vaccine (Live/Attenuated).
Vitamin B6
The therapeutic efficacy of Altretamine can be decreased when used in combination with Pyridoxine.
Yellow Fever Vaccine
The risk or severity of adverse effects can be increased when Altretamine is combined with Yellow Fever Vaccine.
Yellow-Fever Virus Vaccine, 17D-204 strain
The risk or severity of adverse effects can be increased when Altretamine is combined with Yellow Fever Vaccine.
